# Lipocine (LPCN) — Earnings

LPCN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lpcn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.41 |
| EPS estimate | −$0.40 |
| EPS surprise | −2.50% |
| Revenue surprise | +171.99% |
| Revenue | $622,849.00 |
| Revenue estimate | $229,000.00 |
| Reported | Aug 5, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1535955/000149315225011588/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 5, 2025 | −$0.40 | −$0.41 | -2.50% | $229,000.00 | $622,849.00 |
| Q1 2025 | May 8, 2025 | −$0.35 | −$0.35 | 0.00% | $352,000.00 | $93,864.00 |
| Q4 2024 | Mar 13, 2025 | −$0.40 | $0.33 | 182.50% | $2.6M | $3.5M |
| Q3 2024 | Nov 7, 2024 | −$0.49 | −$0.44 | 9.28% | $129,500.00 | — |
| Q2 2024 | Aug 8, 2024 | −$0.78 | −$0.56 | 28.21% | $290,000.00 | $89,565.00 |
| Q1 2024 | May 9, 2024 | −$0.68 | $0.66 | 196.75% | — | $7.6M |
| Q4 2023 | Mar 7, 2024 | −$0.47 | −$0.51 | -8.51% | — | $200,000.00 |
| Q3 2023 | Nov 8, 2023 | −$0.60 | −$1.27 | -111.67% | $307,000.00 | — |
| Q2 2023 | Aug 10, 2023 | −$0.64 | −$0.68 | -6.25% | $256,000.00 | — |
| Q1 2023 | May 11, 2023 | −$0.43 | −$0.68 | -60.00% | $777,000.00 | $54,990.00 |
| Q4 2022 | Mar 10, 2023 | −$0.51 | −$0.34 | 33.33% | $1.3M | — |
| Q3 2022 | Nov 9, 2022 | −$0.57 | −$0.51 | 10.01% | $698,667.00 | — |
| Q2 2022 | Aug 8, 2022 | −$0.68 | −$0.68 | 0.00% | $257,000.00 | $500,000.00 |
| Q1 2022 | May 9, 2022 | −$0.34 | −$0.68 | -100.00% | $4.0M | — |
| Q4 2021 | Mar 9, 2022 | −$0.17 | $2.38 | 1500.00% | $5.5M | $16.1M |
| Q3 2021 | Nov 10, 2021 | −$0.72 | −$0.51 | 29.41% | — | $54,994.00 |
| Q2 2021 | Aug 5, 2021 | −$0.85 | −$1.36 | -60.00% | — | — |
| Q1 2021 | May 6, 2021 | −$0.85 | −$0.68 | 20.00% | — | — |
| Q4 2020 | Mar 11, 2021 | −$1.08 | −$3.06 | -184.20% | — | — |
| Q3 2020 | Nov 10, 2020 | −$1.02 | −$1.19 | -16.67% | — | — |

## Frequently Asked Questions

### When did Lipocine (LPCN) last report earnings?

Lipocine last reported on Aug 5, 2025, covering fiscal Q2 2025.

### Did LPCN beat earnings estimates?

No. Lipocine reported EPS of −$0.41 for Q2 2025 against a −$0.40 estimate — a 2.50% miss.

### How much revenue did LPCN report last quarter?

Lipocine reported $622,849.00 in revenue for Q2 2025, against a consensus estimate of $229,000.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).